https://prabadinews.com/
  • October 10, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Drug Trials Snapshot: AVMAPKI FAKZYNJA CO-PACK

Drug Trials Snapshot: AVMAPKI FAKZYNJA CO-PACK

AVMAPKI FAKZYNJA CO-PACK, a combination of avutometinib and defactinib, each kinase inhibitors, is indicated for the treatment of adult patients with KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC) who have received prior systemic therapy.

administrator

Related Articles